LH · 8-K · 20260910PR000201
Guidance / Outlook
LABCORP HOLDINGS INC. · 2026-09-10 · Importance 59 · Surprise 32 · No source text
Labcorp reaffirmed 2026 enterprise revenue guidance of $14.710 billion to $14.827 billion, representing 5.4% to 6.3% growth versus 2025 revenue of $13.952 billion. Diagnostics Laboratories revenue guidance is $11.450 billion to $11.532 billion, up 5.3% to 6.0%, while Biopharma Laboratory Services guidance is $3.269 billion to $3.300 billion, up 5.5% to 6.5%. For 2026, the company also guided to adjusted EPS of $18.10 to $18.55 and free cash flow of $1.240 billion to $1.360 billion. Through 2029, Labcorp expects annual revenue growth of 5% to 8%, adjusted EPS growth of 8.5% to 11.5%, adjusted operating margin expansion of 75 to 150 basis points, and free cash flow growth in line with adjusted earnings growth.
Key facts
- Labcorp's 2026 enterprise revenue guidance is $14,710 million to $14,827 million. source
- Labcorp's 2026 Diagnostics Laboratories revenue guidance is $11,450 million to $11,532 million. source
- Labcorp's 2026 Biopharma Laboratory Services revenue guidance is $3,269 million to $3,300 million. source
- Labcorp's 2026 free cash flow guidance is $1,240 million to $1,360 million. source
- Labcorp expects compound annual revenue growth of 5% to 8% through 2029. source
- Labcorp expects compound annual adjusted EPS growth of 8.5% to 11.5% through 2029. source
- Labcorp's 2026 enterprise revenue growth guidance is 5.4% to 6.3%. source
- Labcorp's 2026 Diagnostics Laboratories revenue growth guidance is 5.3% to 6.0%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | +8.5% | Labcorp expects compound annual adjusted EPS growth of 8.5% to 11.5% through 2029. |
| cash | positive | committed | +6.0% | Labcorp's 2026 free cash flow guidance is $1,240 million to $1,360 million. |
| revenue | positive | committed | +5.5% | Labcorp expects compound annual revenue growth of 5% to 8% through 2029. |
| revenue | positive | committed | +5.0% | Labcorp's 2026 enterprise revenue growth guidance is 5.4% to 6.3%. |
| margin | positive | committed | +1.0% | Labcorp expects adjusted operating margin expansion of 75 to 150 basis points by the end of 2029. |